ITEM VIEW

TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development

dc.contributor.authorKaufmann, Stefan H. E.
dc.contributor.authorDockrell, Hazel M.
dc.contributor.authorDrager, Nick
dc.contributor.authorHo, Mei Mei
dc.contributor.authorMcShane, Helen
dc.contributor.authorNeyrolles, Olivier
dc.contributor.authorOttenhoff, Tom H. M.
dc.contributor.authorPatel, Brij
dc.contributor.authorRoordink, Danielle
dc.contributor.authorSpertini, Francois
dc.contributor.authorStenger, Steffen
dc.contributor.authorThole, Jelle
dc.contributor.authorVerreck, Frank A. W.
dc.contributor.authorWilliams, Ann
dc.contributor.authorConsortium, TBVAC2020
dc.date.accessioned2018-10-09T10:06:53Z
dc.date.available2018-10-09T10:06:53Z
dc.date.issued2017-10
dc.identifier.urihttp://hdl.handle.net/10019.1/104549
dc.description.abstractTBVAC2020 is a research project supported by the Horizon 2020 program of the European Commission (EC). It aims at the discovery and development of novel tuberculosis (TB) vaccines from preclinical research projects to early clinical assessment. The project builds on previous collaborations from 1998 onwards funded through the EC framework programs FP5, FP6, and FP7. It has succeeded in attracting new partners from outstanding laboratories from all over the world, now totaling 40 institutions. Next to the development of novel vaccines, TB biomarker development is also considered an important asset to facilitate rational vaccine selection and development. In addition, TBVAC2020 offers portfolio management that provides selection criteria for entry, gating, and priority settings of novel vaccines at an early developmental stage. The TBVAC2020 consortium coordinated by TBVI facilitates collaboration and early data sharing between partners with the common aim of working toward the development of an effective TB vaccine. Close links with funders and other consortia with shared interests further contribute to this goal.en_ZA
dc.language.isoen_ZAen_ZA
dc.subjectTBVAC2020, Tuberculosis vaccines, Horizon 2020, tuberculosis -- TB, vaccinesen_ZA
dc.titleTBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Developmenten_ZA
dc.typeArticleen_ZA


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

ITEM VIEW